SummaryPropofol may protect neuronal cells from hypoxia re-oxygenation injury, possibly via an antioxidant actions under hypoxic conditions. This study investigated the molecular effects of propofol on hypoxia-induced cell damage using a neuronal cell line. Cultured human IMR-32 cells were exposed to propofol (30 lM) and biochemical and molecular approaches were used to assess cellular effects. Propofol significantly reduced hypoxia-mediated increases in lactate dehydrogenase, a marker of cell damage (mean (SD) for normoxia: 0.39 (0.07) a.u.; hypoxia: 0.78 (0.21) a.u.; hypoxia + propofol: 0.44 (0.17) a.u.; normoxia vs hypoxia, p < 0.05; hypoxia vs hypoxia + propofol, p < 0.05), reactive oxygen species and hydrogen peroxide. Propofol also diminished the morphological signs of cell damage. Increased amounts of catalase, which degrades hydrogen peroxide, were detected under hypoxic conditions. Propofol decreased the amount of catalase produced, but increased its enzymatic activity. Propofol protects neuronal cells from hypoxia reoxygenation injury, possibly via a combined direct antioxidant effect along with induced cellular antioxidant mechanisms. Hypoxia and re-oxygenation events occur under various clinical conditions including intra-and peri-operative brain ischaemia [1][2][3][4][5]. In the brain, hypoxia re-oxygenation often leads to severe cellular damage resulting in a loss of neurological function and a poor clinical outcome [6][7][8]. The underlying mechanisms of hypoxia re-oxygenation injury are multifaceted, but recent studies point towards a central role of reactive oxygen species, which are generated during the hypoxia re-oxygenation [9] and may harm cells by damaging DNA, lipid peroxidation and oxidation of proteins [10].Propofol, a widely used intravenous anaesthetic, has been demonstrated to have neuroprotective properties in several in-vivo [11][12][13][14] and in-vitro [15][16][17] models of cerebral hypoxia re-oxygenation injury. Propofol contains a phenolic hydroxyl group and thus its structure resembles that of a-tocopherol (vitamin E) [18], a natural antioxidant. The antioxidant activity of propofol results partly from this phenolic chemical structure and may be responsible for its cytoprotective effects [19]. Moreover, propofol has been shown to induce and regulate intracellular signalling pathways [20,21] and the neuroprotective effects of propofol may also be mediated indirectly via the induction of cell-based antioxidant mechanisms.In the study presented, we employed an in-vitro model of human neuronal cells to mimic hypoxia reoxygenation events and evaluate the effects of anaesthetic